| Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development J Li, C Ran, E Li, F Gordon, G Comstock, H Siddiqui, W Cleghorn, ... Developmental cell 14 (1), 62-75, 2008 | 262 | 2008 |
| Genetics of glioblastoma: a window into its imaging and histopathologic variability CJ Belden, PA Valdes, C Ran, DA Pastel, BT Harris, CE Fadul, MA Israel, ... Radiographics 31 (6), 1717-1740, 2011 | 80 | 2011 |
| Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation C Ran, H Liu, Y Hitoshi, MA Israel Cancer research 73 (6), 1831-1843, 2013 | 48 | 2013 |
| Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment MC Havrda, BR Paolella, C Ran, KS Jering, CM Wray, JM Sullivan, ... Cancer research 74 (6), 1822-1832, 2014 | 39 | 2014 |
| Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in mice JM Murad, CS Place, C Ran, SKN Hekmatyar, NP Watson, RA Kauppinen, ... Journal of biological chemistry 285 (31), 24164-24173, 2010 | 29 | 2010 |
| Insulin-mediated signaling facilitates resistance to PDGFR inhibition in proneural hPDGFB-driven gliomas DA Almiron Bonnin, C Ran, MC Havrda, H Liu, Y Hitoshi, Z Zhang, ... Molecular Cancer Therapeutics 16 (4), 705-716, 2017 | 28 | 2017 |
| Developmental profiling of microRNAs in the human embryonic inner ear DM Chadly, J Best, C Ran, M Bruska, W Woźniak, B Kempisty, ... PloS one 13 (1), e0191452, 2018 | 24 | 2018 |
| Characterizing the heterogeneity in 5-aminolevulinic acid–induced fluorescence in glioblastoma DAA Bonnin, MC Havrda, MC Lee, L Evans, C Ran, DC Qian, ... Journal of neurosurgery 132 (6), 1706-1714, 2019 | 19 | 2019 |
| ACTIVATION OF ALTERNATIVE RECEPTOR TYROSINE KINASE IN GLIOBLASTOMA MEDIATES RESISTANCE TO PDGFR INHIBITION C Ran, H Liu, Z Zhang, MA Israel, Y Hitoshi JOURNAL OF INVESTIGATIVE MEDICINE 62 (4), 713-713, 2014 | | 2014 |
| Supplemental Experimental procedures TSRI HIV | | |
